![AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research](https://idataresearch.com/wp-content/uploads/2017/10/abbvie-humira.jpg)
AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research
![A Humira Prescription Costs $38,000 A Year Because Our Patent System Is Being Abused | HuffPost Opinion Archive A Humira Prescription Costs $38,000 A Year Because Our Patent System Is Being Abused | HuffPost Opinion Archive](https://img.huffingtonpost.com/asset/5bd0ca34260000450283e139.jpeg?cache=6aDrhpnfiW&ops=1778_1000)
A Humira Prescription Costs $38,000 A Year Because Our Patent System Is Being Abused | HuffPost Opinion Archive
![HUMIRA Cost | adalimumab price | Arthritis treatment | FDA Approval | Online Available In India US UK AE SA BR RU CN HUMIRA Cost | adalimumab price | Arthritis treatment | FDA Approval | Online Available In India US UK AE SA BR RU CN](https://indianpharmanetwork.co.in/images/humira.webp)
HUMIRA Cost | adalimumab price | Arthritis treatment | FDA Approval | Online Available In India US UK AE SA BR RU CN
![HUMIRA Price | Price List or Cost of Generic adalimumab | treatment of rheumatoid arthritis | Price in India HUMIRA Price | Price List or Cost of Generic adalimumab | treatment of rheumatoid arthritis | Price in India](https://specialitypharma.com/assets/img/medicines/humira-adalimumab.jpg)
HUMIRA Price | Price List or Cost of Generic adalimumab | treatment of rheumatoid arthritis | Price in India
![Frontiers | The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures Frontiers | The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures](https://www.frontiersin.org/files/Articles/591134/fphar-11-591134-HTML-r3/image_m/fphar-11-591134-g002.jpg)